Dr Ria David educates us on the current recommendation for cancer patients getting the COVID vaccine. Infection in the immunocompromised population, which includes cancer patients and those on chemotherapy, can lead to excessive morbidity and mortality. It’s therefore imperative, where possible, to protect these individuals against infection.  Immunisation against certain infections is an important and effective means of protecting cancer patients. This, however, needs to be balanced against the decreased potential for these individuals to mount an immune response compared to the unimpaired host. There is also concern over the risk of live vaccines (measles, mumps, rubella, zoster and varicella)…